Trademark: 85389102
Status Date
Monday, March 9, 2015
Filing Date
Thursday, August 4, 2011
Published for Opposition
Tuesday, December 6, 2011
Abandoned Date
Monday, March 9, 2015
5 Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, gastro-intestinal diseases; human pharmaceuticals for use as hemostatic agents
Mar 9, 2015
Abandonment Notice Mailed - No Use Statement Filed
Mar 9, 2015
Abandonment - No Use Statement Filed
Jul 18, 2014
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2014
Extension 5 Granted
Jul 1, 2014
Extension 5 Filed
Jul 1, 2014
Teas Extension Received
Jan 28, 2014
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2014
Extension 4 Granted
Jan 6, 2014
Extension 4 Filed
Jan 6, 2014
Teas Extension Received
Jun 25, 2013
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2013
Extension 3 Granted
Jun 17, 2013
Extension 3 Filed
Jun 17, 2013
Teas Extension Received
Jan 24, 2013
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2013
Extension 2 Granted
Jan 7, 2013
Extension 2 Filed
Jan 23, 2013
Case Assigned To Intent To Use Paralegal
Jan 7, 2013
Teas Extension Received
Jun 26, 2012
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2012
Teas Change Of Correspondence Received
Jun 22, 2012
Extension 1 Granted
Jun 22, 2012
Extension 1 Filed
Jun 22, 2012
Teas Extension Received
Jan 31, 2012
Noa Mailed - Sou Required From Applicant
Dec 6, 2011
Published For Opposition
Nov 16, 2011
Notice Of Publication
Nov 2, 2011
Approved For Pub - Principal Register
Nov 1, 2011
Assigned To Examiner
Aug 9, 2011
New Application Office Supplied Data Entered In Tram
Aug 8, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
